Hasandalan, Krystal .
HRN: 23-83-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/31/2024
CEFTRIAXONE 1G (VIAL)
10/31/2024
11/06/2024
IV DRIP
360mg
Q12
Typhoid Fever
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes